For the first time we could demonstrate that SOD1 inhibition in glioma cells using the small molecule inhibitor ATN-224 sensitizes GB cells towards conditions of the tumor microenvironment including glucose and oxygen deprivation. The gene discussed is SOD1; the disease is central nervous system cancer.